Evie Koslosky
Stock Analyst at Goldman Sachs
(3.02)
# 2,675
Out of 4,974 analysts
38
Total ratings
69.6%
Success rate
6.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Evie Koslosky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRAL GRAIL | Maintained: Hold | $60 | $80.34 | -25.32% | 2 | Sep 9, 2026 | |
| GH Guardant Health | Maintained: Buy | $210 | $161.41 | +30.10% | 7 | Sep 8, 2026 | |
| A Agilent Technologies | Rated: Buy | $155 → $175 | $150.86 | +16.00% | 4 | Aug 27, 2026 | |
| SHC Sotera Health Company | Maintained: Buy | $22 → $24 | $18.90 | +26.98% | 3 | Aug 6, 2026 | |
| DHR Danaher | Maintained: Buy | $210 | $207.66 | +1.13% | 4 | Aug 3, 2026 | |
| MTD Mettler-Toledo International | Maintained: Hold | $1,400 → $1,340 | $1,345.26 | -0.39% | 3 | Jul 31, 2026 | |
| BRKR Bruker | Maintained: Sell | $40 | $58.50 | -31.62% | 4 | Jul 27, 2026 | |
| WAT Waters | Rated: Buy | $380 → $425 | $409.38 | +3.82% | 3 | Jul 14, 2026 | |
| NTRA Natera | Maintained: Hold | $245 → $270 | $328.18 | -17.73% | 3 | Jul 14, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | $27 | $25.07 | +7.70% | 2 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $105 → $100 | $130.22 | -23.21% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $685 | $613.78 | +11.60% | 1 | Dec 9, 2025 |
GRAIL
Sep 9, 2026
Maintained: Hold
Price Target: $60
Current: $80.34
Upside: -25.32%
Guardant Health
Sep 8, 2026
Maintained: Buy
Price Target: $210
Current: $161.41
Upside: +30.10%
Agilent Technologies
Aug 27, 2026
Rated: Buy
Price Target: $155 → $175
Current: $150.86
Upside: +16.00%
Sotera Health Company
Aug 6, 2026
Maintained: Buy
Price Target: $22 → $24
Current: $18.90
Upside: +26.98%
Danaher
Aug 3, 2026
Maintained: Buy
Price Target: $210
Current: $207.66
Upside: +1.13%
Mettler-Toledo International
Jul 31, 2026
Maintained: Hold
Price Target: $1,400 → $1,340
Current: $1,345.26
Upside: -0.39%
Bruker
Jul 27, 2026
Maintained: Sell
Price Target: $40
Current: $58.50
Upside: -31.62%
Waters
Jul 14, 2026
Rated: Buy
Price Target: $380 → $425
Current: $409.38
Upside: +3.82%
Natera
Jul 14, 2026
Maintained: Hold
Price Target: $245 → $270
Current: $328.18
Upside: -17.73%
Caris Life Sciences
Jul 1, 2026
Maintained: Buy
Price Target: $27
Current: $25.07
Upside: +7.70%
May 6, 2026
Maintained: Hold
Price Target: $105 → $100
Current: $130.22
Upside: -23.21%
Dec 9, 2025
Initiated Coverage: Buy
Price Target: $685
Current: $613.78
Upside: +11.60%